Overexpression of Lipocalin-2 Inhibits Proliferation and Invasiveness of Human Glioblastoma Multiforme Cells by Activating ERK Targeting Cathepsin D Expression

Overview

Journal Biology (Basel)

Publisher MDPI

Specialty Biology

Date 2021 Jun 2

PMID 34062746

Citations 5

Authors

Yi-Hsien Hsieh

Jen-Pi Tsai

Chen-Lin Yu

Chu-Che Lee

Jen-Chieh Hsu

Jin-Cherng Chen

Affiliations

Soon will be listed here.

Abstract

Lipocalin-2 (LCN2) exhibits pro- and anti-carcinogenic effects in several cancers, but its role in the progression of glioblastoma multiforme (GBM) remains unclear. This study aims to elucidate the effect of LCN2 in human GBM cell, and the mechanism underlying its effects on GBM malignant progression. We observed that LCN2 expression was significantly lower in GBM than in normal tissues and was associated with poorer GBM patient survival. LCN2-overexpressing GBM cells showed significantly reduced proliferation and migration/invasion abilities. Human protease antibody array analysis showed that the expression of cathepsin D (CTSD) protein and mRNA was lower in LCN2-overexpressing GBM cells than in controls. Higher CTSD expression was observed in GBM tumors than in normal tissues, and higher CTSD expression was associated with poorer overall and disease-free survival. LCN2-overexpressing GBM cells exhibited increased ERK phosphorylation. Treatment of these cells with a MEK inhibitor (U0126) restored CTSD expression, cell migration, and cell invasiveness. In conclusion, LCN2 might be serving as a prognostic marker and promising anti-proliferative and anti-metastatic target for treating GBM.

Citing Articles

IL-17 Mildly Rescued the Impaired Proliferation of Alveolar Epithelial Cells Induced by LCN2 Overexpression.

Lv T, Hou Z, Yang K, Wang J Can Respir J. 2024; 2024:9284430.

PMID: 39139502 PMC: 11321888. DOI: 10.1155/2024/9284430.

mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses.

Azimi P, Yazdanian T, Ahmadiani A BMC Cancer. 2024; 24(1):612.

PMID: 38773447 PMC: 11106946. DOI: 10.1186/s12885-024-12345-z.

Miniaturized microarray-format digital ELISA enabled by lithographic protein patterning.

Stephens A, Song Y, McClellan B, Su S, Xu S, Chen K Biosens Bioelectron. 2023; 237:115536.

PMID: 37473549 PMC: 10528924. DOI: 10.1016/j.bios.2023.115536.

Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.

Huang Z, Rui X, Yi C, Chen Y, Chen R, Liang Y J Exp Clin Cancer Res. 2023; 42(1):60.

PMID: 36899380 PMC: 10007849. DOI: 10.1186/s13046-023-02618-z.

Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.

Ma Y, Xi Z Oxid Med Cell Longev. 2022; 2022:9993319.

PMID: 36193073 PMC: 9526634. DOI: 10.1155/2022/9993319.

References

Santiago-Sanchez G, Pita-Grisanti V, Quinones-Diaz B, Gumpper K, Cruz-Monserrate Z, Vivas-Mejia P . Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer. Int J Mol Sci. 2020; 21(12). PMC: 7352275. DOI: 10.3390/ijms21124365. View

Holzen L, Parigiani M, Reinheckel T . Tumor cell- and microenvironment-specific roles of cysteine cathepsins in mouse models of human cancers. Biochim Biophys Acta Proteins Proteom. 2020; 1868(7):140423. DOI: 10.1016/j.bbapap.2020.140423. View

Fukuda M, Iwadate Y, Machida T, Hiwasa T, Nimura Y, Nagai Y . Cathepsin D is a potential serum marker for poor prognosis in glioma patients. Cancer Res. 2005; 65(12):5190-4. DOI: 10.1158/0008-5472.CAN-04-4134. View

Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson E . Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer. 2007; 120(11):2426-34. DOI: 10.1002/ijc.22352. View

Liu Y, Zhou Y, Zhu K . Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion. PLoS One. 2012; 7(9):e45910. PMC: 3461042. DOI: 10.1371/journal.pone.0045910. View

Wu X, Hu A, Zhang M, Chen Z . Effects of Rab27a on proliferation, invasion, and anti-apoptosis in human glioma cell. Tumour Biol. 2013; 34(4):2195-203. DOI: 10.1007/s13277-013-0756-5. View

Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q . Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Prostate. 2015; 75(9):957-68. DOI: 10.1002/pros.22978. View

Zhao Y, Xia Q, Liu Y, Bai W, Yao Y, Ding J . TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cells. Cell Signal. 2018; 55:8-16. DOI: 10.1016/j.cellsig.2018.12.007. View

Tong Z, Kunnumakkara A, Wang H, Matsuo Y, Diagaradjane P, Harikumar K . Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 2008; 68(15):6100-8. PMC: 2714276. DOI: 10.1158/0008-5472.CAN-08-0540. View

10.

Thakkar J, Dolecek T, Horbinski C, Ostrom Q, Lightner D, Barnholtz-Sloan J . Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):1985-96. PMC: 4185005. DOI: 10.1158/1055-9965.EPI-14-0275. View

11.

Arbab A, Rashid M, Angara K, Borin T, Lin P, Jain M . Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma. Int J Mol Sci. 2017; 18(12). PMC: 5751333. DOI: 10.3390/ijms18122732. View

12.

Yang S, Chen Y, Chien H, Wang K, Lin C, Chiou H . Melatonin attenuates epidermal growth factor-induced cathepsin S expression in ARPE-19 cells: Implications for proliferative vitreoretinopathy. J Pineal Res. 2019; 68(1):e12615. DOI: 10.1111/jpi.12615. View

13.

Ikeguchi M, Sakatani T, Ueta T, Fukuda K, Oka S, Hisamitsu K . Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma. J Clin Pathol. 2002; 55(2):121-6. PMC: 1769587. DOI: 10.1136/jcp.55.2.121. View

14.

Zhang H, Xu L, Xiao D, Xie J, Zeng H, Wang Z . Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol. 2007; 60(5):555-61. PMC: 1994524. DOI: 10.1136/jcp.2006.039297. View

15.

Du Z, Wu B, Xie Y, Zhang Y, Liao L, Zhou F . Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop. Biochim Biophys Acta. 2015; 1853(10 Pt A):2240-50. DOI: 10.1016/j.bbamcr.2015.07.007. View

16.

Marenco-Hillembrand L, Wijesekera O, Suarez-Meade P, Mampre D, Jackson C, Peterson J . Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. J Neurooncol. 2020; 147(2):297-307. DOI: 10.1007/s11060-020-03451-6. View

17.

Rock K, McArdle O, Forde P, Dunne M, Fitzpatrick D, ONeill B . A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?. Br J Radiol. 2012; 85(1017):e729-33. PMC: 3487092. DOI: 10.1259/bjr/83796755. View

18.

Joyce J, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai F . Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell. 2004; 5(5):443-53. DOI: 10.1016/s1535-6108(04)00111-4. View

19.

Zheng L, Lee S, Yin G, Mori K, Suk K . Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells. J Neurochem. 2009; 111(5):1238-51. DOI: 10.1111/j.1471-4159.2009.06410.x. View

20.

Lee H, Lee E, Lee K, Hong S, Yoon Y, Kim J . Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer. 2005; 118(10):2490-7. DOI: 10.1002/ijc.21657. View